Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription


2 Ann Surg Oncol
3 BMC Cancer
1 BMC Gastroenterol
1 Br J Cancer
1 Cancer Lett
1 Cancer Res
1 Clin Cancer Res
1 Curr Treat Options Oncol
8 Dis Colon Rectum
1 Eur J Cancer
1 Gastroenterology
5 Int J Cancer
2 Int J Colorectal Dis
4 J Natl Cancer Inst
1 J Nucl Med
1 Lancet Oncol
1 Oncogene
3 PLoS One

    Ann Surg Oncol

  1. KHAN MMM, Munir MM, Woldesenbet S, Endo Y, et al
    Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
    Ann Surg Oncol. 2024 Feb 15. doi: 10.1245/s10434-024-15029.
    >> Share

  2. RAOOF M, Whelan RL, Sullivan KM, Ruel C, et al
    Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
    Ann Surg Oncol. 2023;30:7814-7824.
    >> Share

    BMC Cancer

  3. JIANG Y, Zhao M, Tang W, Zheng X, et al
    Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis.
    BMC Cancer. 2024;24:188.
    >> Share

  4. TANG Y, Liu Y, Wang X, Guo H, et al
    OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-beta/Smad signaling pathway.
    BMC Cancer. 2024;24:204.
    >> Share

  5. HITCHCOCK KE, Miller ED, Shi Q, Dixon JG, et al
    Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (
    BMC Cancer. 2024;24:201.
    >> Share

    BMC Gastroenterol

  6. TAKADA K, Imai K, Yamada T, Ohata K, et al
    Efficacy of endoscopic submucosal resection with a ligation device for small rectal neuroendocrine tumor: study protocol of a multicenter open-label randomized control trial (BANDIT trial).
    BMC Gastroenterol. 2024;24:69.
    >> Share

    Br J Cancer

  7. PRETE AA, Angerilli V, Bergamo F, Vettore V, et al
    HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study.
    Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-023-02569.
    >> Share

    Cancer Lett

  8. POTHURAJU R, Khan I, Jain M, Bouvet M, et al
    Colorectal cancer murine models: Initiation to metastasis.
    Cancer Lett. 2024 Feb 13:216704. doi: 10.1016/j.canlet.2024.216704.
    >> Share

    Cancer Res

  9. LIU X, Wang X, Yang Q, Luo L, et al
    Th17 cells secrete TWEAK to trigger epithelial-mesenchymal transition and promote colorectal cancer liver metastasis.
    Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2123.
    >> Share

    Clin Cancer Res

  10. SINGH H, Sahgal P, Kapner K, Corsello SM, et al
    RAS/RAF co-mutation and ERBB2 copy number modulates HER2 heterogeneity and responsiveness to HER2-directed therapy in colorectal cancer.
    Clin Cancer Res. 2024 Feb 12. doi: 10.1158/1078-0432.CCR-23-2581.
    >> Share

    Curr Treat Options Oncol

  11. NAIR KG, Kamath SD, Chowattukunnel N, Krishnamurthi SS, et al
    Preoperative Strategies for Locally Advanced Colon Cancer.
    Curr Treat Options Oncol. 2024 Feb 13. doi: 10.1007/s11864-024-01184.
    >> Share

    Dis Colon Rectum

  12. CHEN KA, Goffredo P, Butler LR, Joisa CU, et al
    Prediction of Pathologic Complete Response for Rectal Cancer Based on Pretreatment Factors Using Machine Learning.
    Dis Colon Rectum. 2024;67:387-397.
    >> Share

  13. RUTEGARD M, Svensson J, Segelman J, Matthiessen P, et al
    Anastomotic Leakage in Relation to Type of Mesorectal Excision and Defunctioning Stoma Use in Anterior Resection for Rectal Cancer.
    Dis Colon Rectum. 2024;67:398-405.
    >> Share

  14. WILLIAMS H, Thompson HM, Lin ST, Verheij FS, et al
    Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.
    Dis Colon Rectum. 2024;67:369-376.
    >> Share

  15. OGILVIE JW JR, Khan MT, Hayakawa E, Parker J, et al
    Low Dose Rivaroxaban as Extended Prophylaxis Reduces Postdischarge Venous Thromboembolism in Patients With Malignancy and Inflammatory Bowel Disease.
    Dis Colon Rectum. 2023 Nov 20. doi: 10.1097/DCR.0000000000003107.
    >> Share

  16. SOCHA J, Bujko K
    Repopulation of Rectal Cancer May Explain Worse Local Control After Short-Course Radiation Therapy in the RAPIDO Trial.
    Dis Colon Rectum. 2024;67:e204-e205.
    >> Share

  17. BANERJEE S, Burke CA, Sommovilla J, Anderson CE, et al
    Risk of Proctectomy After Ileorectal Anastomosis in Familial Adenomatous Polyposis in the Modern Era.
    Dis Colon Rectum. 2024;67:427-434.
    >> Share

  18. MARINELLO F, Fraccalvieri D, Planellas P, Adell Trape M, et al
    Sacral Neuromodulation in Patients With Low Anterior Resection Syndrome: The SANLARS Randomized Clinical Trial.
    Dis Colon Rectum. 2024;67:435-447.
    >> Share

  19. TYLER KM, Sentovich SM
    What Every Colorectal Surgeon Should Know About the American Medical Association/Specialty Society Relative Value Scale Update Committee.
    Dis Colon Rectum. 2024;67:351-354.
    >> Share

    Eur J Cancer

  20. ARAI H, Yang Y, Baca Y, Millstein J, et al
    Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
    Eur J Cancer. 2024;201:113914.
    >> Share


  21. LOMBARDI P, Pinato DJ
    Beyond time and space: charting dynamic evolution of sporadic colorectal cancer.
    Gastroenterology. 2024 Feb 8:S0016-5085(24)00162.
    >> Share

    Int J Cancer

  22. BREEKVELDT ECH, Ykema BLM, Bisseling TM, Moons LMG, et al
    Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy.
    Int J Cancer. 2023 Dec 27. doi: 10.1002/ijc.34810.
    >> Share

  23. JIANG PC, Wang SW, Li C, Fan J, et al
    UGT1A1 genotype-guided irinotecan dosing during neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A prospective analysis of SN-38 concentration.
    Int J Cancer. 2024;154:1484-1491.
    >> Share

  24. WEIJERS DD, Hirsch S, Bakhuizen JJ, van Engelen N, et al
    Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations.
    Int J Cancer. 2024;154:1455-1463.
    >> Share

  25. CHEN J, Terry MB, Dalerba P, Hur C, et al
    Environmental drivers of the rising incidence of early-onset colorectal cancer in the United States.
    Int J Cancer. 2024 Feb 10. doi: 10.1002/ijc.34887.
    >> Share

  26. OYELERE AM, Kok DE, Bos D, Gunter MJ, et al
    Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all-cause mortality.
    Int J Cancer. 2024 Feb 12. doi: 10.1002/ijc.34879.
    >> Share

    Int J Colorectal Dis

  27. STELZNER S, Mehdorn M, Puffer E, Bleyl D, et al
    Sidedness is not a prognostic factor in an unselected cohort of patients with colon cancer but prognosis for caecal carcinoma is worse - A multivariate analysis of a large single institution database.
    Int J Colorectal Dis. 2024;39:27.
    >> Share

  28. LI CW, Li XY, Xue FS
    Letter to the editor regarding "A prospective randomized study of multimodal analgesia combined with single injection transversus abdominis plane block versus epidural analgesia against postoperative pain after laparoscopic colon cancer surgery".
    Int J Colorectal Dis. 2024;39:26.
    >> Share

    J Natl Cancer Inst

  29. GOPALANI SV, Senkomago V, Rim SH, Saraiya M, et al
    Human papillomavirus-associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates-United States, 2001-2019.
    J Natl Cancer Inst. 2024;116:275-282.
    >> Share

  30. MAHLA RS
    RE: Autoimmune disease and the risk of anal cancer in the US elderly population.
    J Natl Cancer Inst. 2024;116:338-339.
    >> Share

  31. HOWLADER N, Bhattacharya M, Scoppa S, Miller D, et al
    Cancer and COVID-19: US cancer incidence rates during the first year of the pandemic.
    J Natl Cancer Inst. 2024;116:208-215.
    >> Share

  32. SONG M, Engels EA, Clarke MA, Kreimer AR, et al
    Autoimmune disease and the risk of anal cancer in the US population aged 66 years and over.
    J Natl Cancer Inst. 2024;116:309-315.
    >> Share

    J Nucl Med

  33. TIKUM AF, Ketchemen JP, Doroudi A, Nambisan AK, et al
    Effectiveness of (225)Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models.
    J Nucl Med. 2024 Feb 15:jnumed.123.266204. doi: 10.2967/jnumed.123.266204.
    >> Share

    Lancet Oncol

  34. WISSE PHA, de Klaver W, van Wifferen F, van Maaren-Meijer FG, et al
    The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study.
    Lancet Oncol. 2024 Feb 9:S1470-2045(23)00651.
    >> Share


  35. CHEN Z, Zhou J, Wu Y, Chen F, et al
    METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability.
    Oncogene. 2024 Feb 15. doi: 10.1038/s41388-024-02956.
    >> Share

    PLoS One

  36. JONES J, Shi Q, Nath RR, Brito IL, et al
    Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming.
    PLoS One. 2024;19:e0297897.
    >> Share

  37. VERMA A, Bakhtiyar SS, Ali KG, Chervu N, et al
    Early discharge following colectomy for colon cancer: A national perspective.
    PLoS One. 2024;19:e0294256.
    >> Share

  38. XU L, Zhang H, Shao Y, Fu Z, et al
    Correction: Bioinformatics analysis-based screening of circRNA gene with mainstream expression trend in colorectal cancer and construction of a coexpression regulatory network.
    PLoS One. 2024;19:e0298924.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016